Executive Summary
HHS commits $405M across 11 contracts in 2025, with 45% ($182M) in top 3 awards to pharma manufacturing ($140M Chartwell RX) and IT services ($73M Peraton, $29M Sapient), signaling priorities in preparedness stockpiling and digital modernization. Five bullish signals on small business set-asides provide revenue visibility to 2029, with 60% average outlay execution in mature deals. Neutral signals dominate nonprofits/JVs, but option upside totals $200M+ warrants monitoring for growth.
Tracking the trend? Catch up on the prior All HHS Contracts digest from December 29, 2025.
Investment Signals(5)
- Pharma manufacturing set-aside for antibiotics(HIGH)▲
$140M fully obligated to Chartwell RX through Dec 2025 supports committed revenue amid HHS preparedness focus.
- NIH IT/computing services expansion potential(HIGH)▲
$27M obligated to Sapient with $90M option ceiling to 2029 indicates multi-year revenue ramp.
- Small business IT payroll O&M lock-in(HIGH)▲
$17M early outlay to Lyceum with $40M potential through 2029 via set-aside secures long-term HHS spend.
- FDA pathology services steady execution(MEDIUM)▲
$24M with 79% outlay to Toxicologic Pathology through Sep 2025 highlights reliable small business delivery.
- IHS consulting for accreditation compliance(MEDIUM)▲
$9M firm-fixed to Bryant SDB positions for tribal health support amid short 1-year window.
Risk Flags(3)
- Execution[HIGH RISK]▼
Firm-fixed-price structures across 5 contracts ($214M total) expose to cost overruns without adjustment.
- Execution[MEDIUM RISK]▼
Time-and-materials pricing in 4 contracts ($54M) risks labor hour/rate scrutiny and audits.
- Market[MEDIUM RISK]▼
Unexercised options ($200M+ potential) in 7 contracts vulnerable to HHS budget shifts.
Opportunities(3)
- ◆
$200M+ in unexercised options across IT/health services contracts to 2029.
- ◆
Small/SDB set-asides (6 of 11 contracts, $230M) favor follow-ons in preparedness/IT.
- ◆
High outlay execution (avg 65%) in 2025-ending contracts signals closeout cash flows.
Sector Themes(3)
- ◆
$144M (36%) in antibiotics/pathology/staffing underscores HHS ASPR/FDA antibiotic and medical readiness focus.
- ◆
$114M (28%) across data centers, computing, payroll signals multi-year digitization push by NIH/PSC.
- ◆
Ongoing CDC/NIH spend ($110M) in infrastructure/research despite neutral signals on nonprofits/JVs.
Watch List(3)
- 👁
{"entity"=>"Chartwell RX LLC", "reason"=>"Largest award ($140M, 35% total) fully obligated with $99M outlay; 2025 closeout pivotal.", "trigger"=>"Extension beyond Dec 2025 or new ASPR awards"}
- 👁
{"entity"=>"Lyceum Business Services, LLC", "reason"=>"$17M early outlay with $40M potential to 2029; newest high-upside set-aside.", "trigger"=>"Option exercises adding $23M by 2026"}
- 👁
{"entity"=>"Sapient Government Services, Inc.", "reason"=>"$27M obligated with $63M option expansion to 2029; rapid $13M outlay post-award.", "trigger"=>"NIH NLM funding for full $90M ceiling"}
Get daily alerts with 5 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 11 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC